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The expression of secretory component (SC) by human 
glandular endometrial cells cultured in vitro was signifi- 
cantly increased by estradiol in the medium. Interferon- 
gamma and interleukin-4 stimulated the expression of SC 
only in the presence of estrogen. Tumor necrosis factor- 
alpha plus estrogen also caused a significant increase in 
the number of cells expressing SC. HLA class II antigen 
DR was detected on few glandular epithelial cells of 
human endometrium cultured in control medium, 
whereas interferon-gamma and interleukin-4, but not tu- 
mor necrosis factor-alpha, caused significant increases in 
the expression of DR. Estrogen in the culture medium did 
not significantly affect DR expression. The human en- 
dometrial adenocarcinoma cell lines, HEC and RL-95, 
expressed SC in approximately 50 and 20% of the cells. 
Also, approximately 20% of the RL-95 cells stained for 
DR antigen. Interferon-gamma did not influence the de- 
gree of expression of either surface marker of the two cell 
lines. Cells of both lines bound polymeric IgA and IgM 
but showed little to no binding of monomeric IgA, IgG, or 
an IgM previously shown not to bind SC. 
KEY WORDS: Endometrial cells; cytokines; estrogen; secretory 
component; DR antigen. 
INTRODUCTION 
The female genital tract is one of the organs and 
tissues that compose the common mucosal immune 
1Department of Obstetrics and Gynecology, University of Mich- 
igan, Ann Arbor, Michigan 48109. 
ZDepartment of Microbiology, University of Alabama at Bir- 
mingham, Birmingham, Alabama 35294. 
3To whom correspondence should be addressed at Department 
of Obstetrics and Gynecology, L1221 Women's Hospital, Uni- 
versity of Michigan Medical Center, 1500 East Medical Center 
Drive, Ann Arbor, Michigan 48109-0278. 
259 
system also known as the secretory immune system 
(1, 2). The mucosal immune system secretes more 
immunoglobulin (Ig), primarily of the IgA isotype, 
than the total Ig of all classes originating from bone 
marrow, spleen, and lymph nodes combined (3). 
Secreted IgA functions as the first line of defense 
for the mucosal surfaces. Both serum-derived and 
locally produced antibodies are found in the cervi- 
covaginal secretions of women (4-9). 
An integral part of the secretory immune system 
is the secretory component (SC), the receptor for 
polymeric Ig (pig) (10). The transport of plgA or 
pentameric IgM, produced by the plasma cells 
located in the subepithetial tissues, to the lumen of 
mucosal organs is dependent on the expression of 
SC on epithelial cells that binds the pig on the 
basolateral surface. The SC-plg complex is inter- 
nalized, transported to the apical surface, and se- 
creted into the lumen as S-IgA or S-IgM. Glandular 
epithelial cells from the human fallopian tubes, 
uterine endometrium, and cervix have been shown 
to produce and express surface SC (11-14). The 
secretion and expression of SC by the endometrium 
appears to be influenced by the stage of the men- 
strual cycle (11, 14). In addition, adenocarcinomas 
of the human endometrium also express SC on the 
epithelial surface (11, 15). 
The HLA class II antigen, DR, which is ex- 
pressed typically on antigen-processing cells, has 
been also demonstrated on the glandular epithelial 
cells of the endometrium (16). The expression of SC 
and DR on some cells and cell lines is modulated by 
cytokines such as interferon-gamma (IFN--/), inter- 
leukin-4 (IL-4), and tumor necrosis factor-alpha 
(TNF-a), all produced by T cells, suggesting roles 
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for these molecules in mucosal immune responses 
(17-20). 
The purpose of the present study was to examine 
the effects of different recombinant cytokines and 
estrogen on the expression of SC and DR on glan- 
dular epithelial cells from the human endometrium 
and two cell lines cloned from human endometrial 
adenocarcinomas. 
MATERIALS AND METHODS 
Endometrial Glandular Epithelial Cells 
Samples of normal endometrium were obtained 
from six women undergoing surgery for nonneopla- 
sic indications. Their age ranged from 35 to 45 
years. The specimens were obtained primarily dur- 
ing the proliferative stage of the menstrual cycle. 
The tissues were maintained on ice until the endo- 
metrium was carefully dissected free of myo- 
metrium and cut into 5- to 8-mm sections for 
processing. The tissue was placed in 6-8 ml of 0.2% 
collagenase (Type II, Sigma Chemical Co, St. 
Louis, MO), 0.01% DNAase (Sigma) in 20 mM 
Hepes (Sigma)-buffered RPMI 1640 cell culture 
medium (CM) (Cellgro Mediatech, Washington, 
DC) (21). Digestion was performed at 37°C with 
constant stirring for 30 min before the supernatant 
was replaced with fresh enzyme medium; three or 
four digestions were done, until the endometrial 
tissue was completely dispersed. The digested sam- 
ples were mixed with an equal volume of CM 
containing 10% fetal calf serum (FCS) (Flow Labo- 
ratories, McLean, VA) in 15-ml conical centrifuge 
tubes and placed on ice. After 10-15 min the glands 
which settled to the bottom of the tubes were 
removed and resuspended in fresh CM-FCS to 
repeat the sedimentation process. The fractions 
containing primarily uterine glands suspended in 
10% FCS in CM were plated in 25-cm 2 culture flasks 
(Coming, Corning, NY) for 1 hr, which allowed the 
stromal cells to attach to the plastic surface (22). 
Epithelial glands did not firmly attach to the plastic 
surface during that interval. If stromal cells re- 
mained in the cell suspension, it was replated again 
for another hour. The CM containing the glands was 
removed from the flasks and distributed into a 
24-well plate (Corning). The cells were allowed to 
reach confluency, usually occurring within 3-5 
days, at which point treatment with cytokines was 
initiated. The CM was changed at 48 hr and at the 
start of the treatments. Estradiol-17B (E2) (Sigma) 
was added beginning the first day to some of the 
cultures at a 10 .9  M final concentration. 
Endometrial Adenocarcinoma Cell Lines 
Two cell lines, HEC-1-A and RL95-2, were ob- 
tained from American Type Culture Collection, 
Rockville, MD. The lines were cultured in RPMI 
1640 containing 10% FCS, 5 ~g bovine insulin, 100 
U penicillin, and 50 Ixg streptomycin (Sigma) per 
ml. 
Cytokines 
The cytokines were added to the culture medium 
at the following concentrations per milliliter: 200- 
2000 U IFN-~/(Boehringer Mannheim, Germany), 2 
ng IL-4, and 2 ng TNF-a (R&D Systems, Minneap- 
olis, MN). 
Immunofluorescence 
The endometrial cells were removed from the 
wells of the plates by using trypsin-EDTA. After 
stripping, cells were resuspended in the CM at 
approximately 5 x 10 6 cel ls /ml  and 50-~1 aliquots 
were pipetted into 1-ml microcentrifuge tubes and 
placed in a CO2 incubator for 2-2.5 hr to allow 
reexpression of surface markers (19). The cells were 
then centrifuged at 200g for 4 min, the supernatant 
removed, and 20 p~l of labeled or unlabeled antibod- 
ies to SC or DR added to each tube. The samples 
were incubated on ice for 30 min, then washed twice 
with cold PBS, and if the antibodies were directly 
labeled with fluorochromes, the cells were fixed with 
1% paraformaldehyde for 20 min, washed with PBS, 
and mounted on a microslide for fluorescent micro- 
scopic observation. Coverslips were sealed using 
clear fingernail polish. If the first antibody was 
unlabeled, a second antibody (anti-Ig) labeled with 
fluorescein isothiocyanate (FITC) or tetramethyl 
rhodamine isothiocyanate (TRITC) was used with 
the cells after the wash. The antibodies consisted of 
the afffinity-purified IgG fraction of goat anti-human 
secretory component conjugated with FITC or 
TRITC (Dako, Carpinteria, CA), monodonal anti- 
bodies against HLA class II antigen (DR), and anti- 
cytokeratin peptide 16 (Becton Dickinson, Mountain 
View, CA). The second antibody, goat anti-mouse 
IgG labeled with FITC, was produced in the labora- 
tory of JM. A minimum of 200 cells was counted for 
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each labeled preparation. Slides were examined us- 
ing a Leitz orthoplan microscope (Leitz Co., Wet- 
zlar, Germany) with a superhigh-pressure mercury 
lamp. 
Immunoglobulins 
Human mIgA, pIgA, and IgM were isolated from 
serum samples of patients with IgA and IgM myelo- 
mas and IgG from normal human serum using 
classical Ig purification methods. (23, 24) Ten mi- 
crograms of the Ig's was added to suspensions of 
HEC and RL-95 cells (× 106) and kept on ice for 60 
rain. The cells were washed twice with cold PBS, 
exposed to biotinylated-F(ab')2 antibodies against 
human IgA, IgG, or IgM (Tago, Burlingame, CA) 
for 45 min, and washed twice, and then avidin:FITC 
(Sigma) was added for a 30-rain incubation on ice. 
The cells were again washed, fixed, mounted, and 










Fig. 1. Expression of SC on endometrial gland epithelial cells 
modulated by E 2 (10-9M) and stimulated for 48 hr with 200 U/ml 
IFN-% 2 ng/ml of IL-4, or 2 ng/ml of TNF-e~ alone or in 
combination. After 48 hr the cells were harvested and labeled 
with anti-SC antibodies. 
Statistics 
The data were analyzed by Student's t test and 
are p•esented as percentage mean + standard error 
of the mean (SE). 
RESULTS 
The cell cultures of the endometrial glands pos- 
sessed the characteristics of epithelial cells in 
monolayer, as they appeared polyhedral in shape 
and arranged in swirls. Upon staining the epithelial 
cell cultures with the anticytokeratin antibody, 
more than 95% of the cells displayed cytoplasmic 
reactivity. 
In the absence of E2, 6 + 3.2% of the epithelial 
cells displayed detectable SC on the surface (Fig. 
1). The addition of the cytokines IFN-y and IL-4 to 
the CM resulted in small and nonsignificant in- 
creases in the number of cells expressing SC. How- 
ever, after adding E2 to the medium, the incidence 
of cells with detectable surface SC increased to 21 
--+ 3.1%. With E2 present in the CM, the addition of 
the cytokines resulted in a further enhancement in 
the number of cells expressing SC: the addition of 2 
ng of TNF-a increased the percentage to 39 --- 6.9% 
and the combination of IFN-y and IL-4 to 37 __+ 
3.5%. The combination of IFN-~ and TNF-a did not 
enhance SC expression above that induced by 
TNF-c~ alone (32 ___ 2.5 vs 39 _-_ 6.9%). 
DR antigen expression on the epithelial cell sur- 
face was independent of the presence of E 2 (Fig. 2). 
Less than 6% of the cells were DR+ in the absence 
of any cytokines or Ez in the media. The addition of 
IFN-y to media without or with E2 induced 68 --- 6.4 
and 68 ___ 8.2% of the cells to express DR. IL-4 
treatment resulted in 53 ___ 5.8 and 44 __. 4.1% of the 
cells being DR+ and TNF-c~ induced approximately 
1t ___ 2.0% positive cells. In comparison with IFN-~/ 
i 
80. 
• E 2  + E 2  
Fig. 2. Expression of DR antigen on endometrial gland epithelial 
cells cultured without and with Ez (10-9 M) and stimulated for 48 
hr with 200 U/rnl IFN-y, 2 ng/ml IL-4, or 2 ng/ml of TNF-a  alone 
or in combination. After 48 hr the cells were harvested and 
labeled with anti-DR antibodies. 
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HEC - Cell lines - RL95 
Fig. 3. Lack of influence of IFN--y on SC expression by endo- 
metrial cell lines HEC and RL95. Cytokine added for 48 hr 
before harvesting and immunofluorescent analysis of SC cell 
surface expression. 
alone, the combination of TNF-c~ with IFN-~/ or 
with IL-4 had little effect on DR expression by the 
epithelial cells. The incidence of epithelial cells 
coexpressing both SC and DR markers was signifi- 
cantly modulated by the cytokine treatment and the 
presence of E2 in the culture media. In media 
without E2, 9-16% of the total cells positive for 
either SC or DR were positive for both antigens. 
With the addition of Ez the percentage of cells 
positive for both markers increased to 29 +- 4.9%. 
Addition of the different cytokines to Ez-stimulated 
cells resulted in coexpression as follows: IFN-~/, 33 
___ 3.2%; IL-4, 38 -+ 5.0%; TNF-cL, 13 -+- 4.3%; 
IFN-~ + IL-4, 40 --- 3.8%; and IFN-~/+ TNF-~, 26 
_ 6.1%. 
The average incidence of cells positive for SC in 
the HEC line was 54 ___ 9.7 and 19 --- 1.5% for RI_~95 
cell line (Fig. 3). The expression of DR antigen was 
limited to the RL-95 cell line with 21 --- 2.5% of the 
cells being positive at confluency. Staining of the 
RL-95 cells for SC and DR indicated between 33 
and 40% of the cells expressed both markers. The 
numbers of cells expressing SC (52.8 --- 8.3 and 20.5 
_ 3.1%) in HEC and RL-95 cell lines or DR (25 - 
4.9%) in RL-95 cells were not significantly affected 
by treatment of the cell cultures with IFN-~ at 2000 
U/ml (n = 4). All of the cells from both cell lines 
exhibited cytoplasmic staining with the FITC- 













HEC - Cell lines - RL95 
Fig. 4. Binding of human Ig's on cell surface of endometrial cell 
lines HEC and RL95. Cells were incubated with purified human 
Ig's, washed, and exposed to FITC-tabeled antibodies against 
the different Ig's. 
25% of HEC and 80% of RL95 cells showed intense 
cytoskeleton staining. 
Binding studies (n = 3) indicated that the majority 
of the HEC cells bound plgA (87 +-- 8.7%) and IgM 
(89 ± 7.9%) but little mlgA (14 -+ 5.3%) and less 
than 1% for IgG and a nonbinding IgM (Fig. 4). The 
percentages of RL-95 cells binding the different Ig's 
were as follows: pIgA, 38 - 3.3%; IgM, 41 --- 7.8%; 
mlgA, 11 _ 3.6%; IgG and nonbinding IgM, 0%. 
DISCUSSION 
The results of our study confirm the report of 
Tabibzadeh et aL (16) that epithelial cells from the 
human endometrium respond to the T-cell cytokine 
IFN-~/by the induction of Class II HLA-DR expres- 
sion on the cell membranes. IFN--¢ has been shown 
to also induce DR antigen on the surface of different 
cell types (18). We report here that IL-4 also 
increased the level of DR expression on the endo- 
metrial cells. 
However, expression of SC on the endometrial 
ceils was also influenced by the gonadal hormone 
estrogen. The effect of progesterone alone or with 
estrogen was not evaluated in the cell culture sys- 
tem. Immunocytochemical evaluation of SC ex- 
pression by the human endometrium suggested, 
however, that secretion occurred throughout the 
menstrual cycle with maximum expression in the 
late secretory phase (11). In vivo studies demon- 
strated the essential role of estrogen in inducing SC 
production by the endometrium in ovariectomized 
Journal of Clinical Immunology, VoL 13, No. 4, 1993 
SC AND DR EXPRESSION ON ENDOMETRIAL CELLS 263 
rats (25). Contrary to the reported IFN-,/enhanced 
uterine SC secretion in ovariectomized rats, we did 
not observe such an increase in human cells cul- 
tured in vitro. The percentage of cells expressing 
membrane SC was shown by Sollid and co-workers 
(20) to be highly" associated with cellular production 
and secretion of SC using HT-29 human colonic 
adenocarcinoma ceils as a model system. 
TNF-o~ exhibited a differential effect on expres- 
sion of the two markers on endometrial cells: it 
significantly enhanced SC expression but showed 
little effect on DR expression. This was similar to 
results reported for colonic cell line HT-29 in which 
SC expression was increased by IFN-~/and TNF-a 
but DR was increased only by IFN-'y (18). If the two 
cytokines were given together a synergistic effect 
on DR expression was then noted. In addition, 
IFN-,/ and IL-4 have demonstrated a synergistic 
effect on SC secretion by HT-29 cells (19). Inflam- 
mation of the gastric epithelial lining also caused an 
upregulation of SC expression, suggesting a role for 
the inflammatory cytokines, i.e., IFN-y and TNF-c~ 
(26). These two cytokines are products of T lym- 
phocytes and macrophages, respectively, which are 
found in elevated numbers in inflammed intestinal 
epithelia. 
The two endometrial adenocarcinoma cell lines, 
unlike the endometrial epithelial cells and the 
HT-29 cell line, were not noticeably modulated as 
to the degree of SC and DR expression by IFN-% 
That the SC molecule on the epithelial cells and the 
cell lines was functional was in part demonstrated 
by its binding to pIgA and pIgM compared with the 
weak to nonexistent binding of mIgA, IgG, and a 
IgM known previously not to bind to SC. The 
incidence of labeled cells increased significantly 
with the indirect detection of SC after the addition 
of plgA and IgM in comparison to direct detection 
of SC with antibody. This observation was noted 
previously in a study on HT-29 cells (19). The 
binding affinity of pIgA for SC was estimated to be 
approximately two orders of magnitude greater than 
that of antibody for SC. 
The endometrium is a mucosal tissue that is 
involved in the transport of pIgA and IgM. As in 
other mucosal tissues and organs, cytokines and 
hormones can enhance the efferent limb of the 
secretory immune system through the up regulation 
of SC production and expression. Epithelial cells 
from various mucosal tissues may respond differen- 
tially to cytokines if regulated by hormones, e.g., 
mammary glands and reproductive tissues are un- 
der primary control of the endocrine system reflect- 
ing their physiological functions of lactation and 
reproduction, whereas intestinal epithelia are di- 
rectly affected by cytokines without the require- 
ment for preconditioning by hormones (1). In the 
absence of Ig-secreting plasma cells in the endome- 
trium, serum-derived pIgA and IgM may be more 
important sources of S-IgA and S-IgM than local 
production. Transport of plgA from the serum 
across the respiratory epithelium has been demon- 
strated in mice (27, 28). We observed similar results 
of the transfer of antibody activity of pIgA from 
serum into the female reproductive tract of mice 
(Renegar, Menge, and Mestecky, unpublished 
work). 
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